Pomerantz Law Firm alerts shareholders who suffered losses on Cassava investment

For over eight decades, Pomerantz LLP has been dedicated to advocating for victims of securities fraud. One of their ongoing cases involves the pharmaceutical company Cassava Sciences (SAVA). The firm is currently representing investors who suffered losses due to alleged violations of federal securities laws by Cassava Sciences.

The class-action lawsuit against Cassava Sciences revolves around accusations that the company misled investors about the results of its clinical trials for a drug meant to treat Alzheimer’s disease. The lawsuit claims that Cassava Sciences made false and misleading statements about the drug’s efficacy, leading to artificial inflation of the company’s stock price. When the truth about the drug’s trial results came to light, investors suffered significant financial losses.

Pomerantz LLP is determined to hold Cassava Sciences accountable for its actions and to seek justice for the investors who were harmed as a result of the alleged securities fraud. The firm is committed to fighting for the rights of investors who have been misled and financially harmed by corporations that prioritize profit over honesty and transparency.

Investors who purchased Cassava Sciences stock between September 14, 2020, and August 27, 2021, are encouraged to participate in the class-action lawsuit. By joining the lawsuit, investors may be eligible to recover some of their losses incurred as a result of the alleged securities fraud perpetrated by Cassava Sciences.

The legal team at Pomerantz LLP is prepared to guide investors through the process of seeking justice and holding Cassava Sciences accountable for its actions. The firm has a long history of success in representing victims of securities fraud and is dedicated to achieving the best possible outcome for their clients.

As the legal battle against Cassava Sciences continues, Pomerantz LLP remains committed to upholding the principles of fairness and honesty in the financial markets. The firm’s dedication to fighting for justice on behalf of investors is unwavering, and they will continue to pursue all legal avenues to ensure that those responsible for securities fraud are held accountable for their actions.

Investors who believe they may have a claim against Cassava Sciences are encouraged to contact Pomerantz LLP to learn more about their legal rights and options. By taking action and holding wrongdoers accountable, investors can help prevent future instances of securities fraud and protect the integrity of the financial markets for all stakeholders.